Adaptive Biotechnologies Corporation
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -34.3% | -34.3% | -22.4% |
| FY2022 | -43.1% | -34.0% | -23.4% |
| FY2023 | -73.0% | -51.3% | -34.1% |
| FY2024 | -78.7% | -47.6% | -29.6% |
| FY2025 | -27.2% | -17.2% | -11.6% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -34.3% | -34.3% | -22.4% |
| FY2022 | -43.1% | -34.0% | -23.4% |
| FY2023 | -73.0% | -51.3% | -34.1% |
| FY2024 | -78.7% | -47.6% | -29.6% |
| FY2025 | -27.2% | -17.2% | -11.6% |